Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$400.86 USD
+6.58 (1.67%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $399.92 -0.94 (-0.23%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/06/2024
Time: AMC |
3/2024 | $4.10 | -1.17% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.20 per share, beating the Zacks Consensus Estimate of $4.10 per share. This reflects a positive earnings surprise of 2.44%. Look out for VRTX's next earnings release on May 06, 2024. For the next earning release, we expect the company to report earnings of $4.10 per share, reflecting a year-over-year increase of 34.43%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services